PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.760
-0.003 (-0.35%)
At close: Apr 28, 2026, 4:00 PM EDT
0.731
-0.029 (-3.82%)
After-hours: Apr 28, 2026, 4:56 PM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.16 million as of April 28, 2026. Its market cap has increased by 4.60% in one year.
Market Cap
8.16M
Enterprise Value
-12.35M
1-Year Change
4.60%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.16M, a decrease of -52.01%. That is a compound annual growth rate of -5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 8.20M | 12.33% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 8.13M |
| BioAtla | 8.07M |
| MetaVia | 8.06M |
| Processa Pharmaceuticals | 7.93M |
| TransCode Therapeutics | 7.81M |
| GridAI Technologies | 7.63M |
| Indaptus Therapeutics | 7.40M |
| Addex Therapeutics | 7.39M |